Nevertheless, RARhoGAP is found to be associated with renal inflammation in diabetic nephropathy via activation of NFκB [71], and also presumably activates JNK or p38 MAPK signaling [72]. This evidence concerns the gene MAPK8 and diabetic kidney disease.